Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$231.97
+2.3%
$236.38
$224.00
$287.32
$67.04B0.451.43 million shs4.73 million shs
DexCom, Inc. stock logo
DXCM
DexCom
$118.77
+0.3%
$131.99
$74.75
$142.00
$47.23B1.232.01 million shs6.07 million shs
3M stock logo
MMM
3M
$100.14
+2.0%
$96.92
$71.12
$106.04
$55.41B14.14 million shs21.75 million shs
ResMed Inc. stock logo
RMD
ResMed
$206.33
-1.4%
$201.75
$132.24
$229.97
$30.31B0.64656,394 shs2.93 million shs
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
-0.03%+1.39%-3.49%-1.42%-4.06%
DexCom, Inc. stock logo
DXCM
DexCom
0.00%-6.75%-6.22%-2.44%+1.29%
3M stock logo
MMM
3M
0.00%+0.47%+3.41%+9.01%+7.32%
ResMed Inc. stock logo
RMD
ResMed
0.00%-3.25%-5.42%+18.17%-2.12%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
4.8838 of 5 stars
2.45.03.34.02.52.52.5
DexCom, Inc. stock logo
DXCM
DexCom
4.9577 of 5 stars
3.45.00.04.72.72.53.1
3M stock logo
MMM
3M
3.7955 of 5 stars
2.13.03.32.82.01.71.3
ResMed Inc. stock logo
RMD
ResMed
4.613 of 5 stars
2.41.03.34.53.91.72.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
2.83
Moderate Buy$280.1720.78% Upside
DexCom, Inc. stock logo
DXCM
DexCom
2.87
Moderate Buy$140.9418.66% Upside
3M stock logo
MMM
3M
2.25
Hold$108.558.39% Upside
ResMed Inc. stock logo
RMD
ResMed
2.70
Moderate Buy$202.80-1.71% Downside

Current Analyst Ratings

Latest DXCM, MMM, BDX, and RMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/30/2024
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$274.00
5/30/2024
DexCom, Inc. stock logo
DXCM
DexCom
Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$130.00
5/28/2024
3M stock logo
MMM
3M
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$112.00 ➝ $118.00
5/16/2024
3M stock logo
MMM
3M
Vertical Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$92.00 ➝ $140.00
5/10/2024
3M stock logo
MMM
3M
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$91.13 ➝ $115.00
5/6/2024
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$305.00 ➝ $312.00
5/1/2024
3M stock logo
MMM
3M
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$98.00 ➝ $100.00
5/1/2024
3M stock logo
MMM
3M
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderperform ➝ Underperform$78.00 ➝ $87.00
5/1/2024
3M stock logo
MMM
3M
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$98.00 ➝ $100.00
5/1/2024
3M stock logo
MMM
3M
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Overweight$110.00 ➝ $111.00
4/26/2024
DexCom, Inc. stock logo
DXCM
DexCom
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetStrong-Buy ➝ Strong-Buy$151.00 ➝ $160.00
(Data available from 6/2/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$19.37B3.46$20.22 per share11.47$88.74 per share2.61
DexCom, Inc. stock logo
DXCM
DexCom
$3.62B13.04$2.07 per share57.40$5.65 per share21.02
3M stock logo
MMM
3M
$32.68B1.70$12.87 per share7.78$8.91 per share11.24
ResMed Inc. stock logo
RMD
ResMed
$4.22B7.18$7.81 per share26.42$31.52 per share6.55

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$1.48B$4.5451.0916.312.036.76%13.90%6.73%8/1/2024 (Estimated)
DexCom, Inc. stock logo
DXCM
DexCom
$541.50M$1.5576.6353.262.9016.82%31.01%10.29%7/25/2024 (Estimated)
3M stock logo
MMM
3M
-$7.00B-$12.72N/A12.791.85-21.57%95.80%10.50%7/23/2024 (Estimated)
ResMed Inc. stock logo
RMD
ResMed
$897.56M$6.5131.6923.662.0420.91%24.43%15.70%8/1/2024 (Estimated)

Latest DXCM, MMM, BDX, and RMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024Q2 24
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$2.97$3.17+$0.20$4.49$5.04 billion$5.05 billion      
4/30/2024Q1 2024
3M stock logo
MMM
3M
$2.10$2.39+$0.29$3.11$7.64 billion$8.00 billion      
4/25/2024Q1 2024
DexCom, Inc. stock logo
DXCM
DexCom
$0.27$0.32+$0.05$0.28$911.20 million$921.00 million    
4/25/2024Q3 24
ResMed Inc. stock logo
RMD
ResMed
$1.91$2.13+$0.22$2.22$1.17 billion$1.20 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$3.801.64%+4.77%83.70%52 Years
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
3M stock logo
MMM
3M
$2.802.80%+0.68%N/A 67 Years
ResMed Inc. stock logo
RMD
ResMed
$1.920.93%+5.66%29.49%12 Years

Latest DXCM, MMM, BDX, and RMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/30/2024
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
quarterly$0.951.62%6/10/20246/10/20246/28/2024
4/25/2024
ResMed Inc. stock logo
RMD
ResMed
Quarterly$0.480.88%5/8/20245/9/20246/13/2024
5/14/2024
3M stock logo
MMM
3M
quarterly$0.702.8%5/23/20245/24/20246/12/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.62
1.41
0.97
DexCom, Inc. stock logo
DXCM
DexCom
1.08
2.90
2.53
3M stock logo
MMM
3M
4.17
1.64
1.27
ResMed Inc. stock logo
RMD
ResMed
0.22
3.04
1.97

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
86.97%
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
3M stock logo
MMM
3M
65.25%
ResMed Inc. stock logo
RMD
ResMed
54.98%

Insider Ownership

CompanyInsider Ownership
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.31%
DexCom, Inc. stock logo
DXCM
DexCom
0.30%
3M stock logo
MMM
3M
0.34%
ResMed Inc. stock logo
RMD
ResMed
1.21%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
73,000289.01 million288.11 millionOptionable
DexCom, Inc. stock logo
DXCM
DexCom
9,600397.68 million396.49 millionOptionable
3M stock logo
MMM
3M
85,000553.36 million551.48 millionOptionable
ResMed Inc. stock logo
RMD
ResMed
10,140146.91 million145.13 millionOptionable

DXCM, MMM, BDX, and RMD Headlines

Recent News About These Companies

Here's Why ResMed (RMD) is a Strong Growth Stock

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Becton, Dickinson and Company logo

Becton, Dickinson and Company

NYSE:BDX
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
DexCom logo

DexCom

NASDAQ:DXCM
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
3M logo

3M

NYSE:MMM
3M Company provides diversified technology services in the United States and internationally. The company's Safety and Industrial segment offers industrial abrasives and finishing for metalworking applications; autobody repair solutions; closure systems for personal hygiene products, masking, and packaging materials; electrical products and materials for construction and maintenance, power distribution, and electrical original equipment manufacturers; structural adhesives and tapes; respiratory, hearing, eye, and fall protection solutions; and natural and color-coated mineral granules for shingles. Its Transportation and Electronics segment provides ceramic solutions; attachment/bonding products, films, sound, and temperature management for transportation vehicles; premium large format graphic films for advertising and fleet signage; light management films and electronics assembly solutions; packaging and interconnection solutions; semiconductor production materials; data centers solutions; and reflective signage for highway, and vehicle safety. The company's Consumer segment provides consumer bandages, braces, supports, and consumer respirators; home cleaning products; retail abrasives, paint accessories, car care DIY products, picture hanging, and consumer air quality solutions; and stationery products. It offers its products through e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers. 3M Company was founded in 1902 and is headquartered in Saint Paul, Minnesota.
ResMed logo

ResMed

NYSE:RMD
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.